(LYLVD) MULTI-UNITS LUXEMBOURG - Ratings and Ratios

Exchange: SW • Country: Switzerland • Currency: EUR • Type: Etf • ISIN: LU0252634307

Description: LYLVD MULTI-UNITS LUXEMBOURG

Additional Sources for LYLVD ETF

Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

LYLVD ETF Overview

Market Cap in USD 207m
Category Trading - Leveraged/Inverse Equity
TER 0.35%
IPO / Inception 2006-06-01

LYLVD ETF Ratings

Growth Rating 80.2
Fundamental -
Dividend Rating 0.0
Rel. Strength 44
Analysts -
Fair Price Momentum 250.58 EUR
Fair Price DCF -

LYLVD Dividends

Currently no dividends paid

LYLVD Growth Ratios

Growth Correlation 3m 65%
Growth Correlation 12m 94%
Growth Correlation 5y 68.8%
CAGR 5y 22.01%
CAGR/Max DD 5y 0.45
Sharpe Ratio 12m 2.51
Alpha 48.18
Beta 1.216
Volatility 26.73%
Current Volume 0k
Average Volume 20d 0k
Stop Loss 253.6 (-3.5%)
What is the price of LYLVD shares?
As of July 12, 2025, the stock is trading at EUR 262.75 with a total of 0 shares traded.
Over the past week, the price has changed by +5.06%, over one month by +4.00%, over three months by +39.73% and over the past year by +64.24%.
Is MULTI-UNITS LUXEMBOURG a good stock to buy?
Yes. Based on ValueRay's Analyses, MULTI-UNITS LUXEMBOURG (SW:LYLVD) is currently (July 2025) a good stock to buy. It has a ValueRay Growth Rating of 80.24 and therefor a clear technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of LYLVD is around 250.58 EUR . This means that LYLVD is currently overvalued and has a potential downside of -4.63%.
Is LYLVD a buy, sell or hold?
MULTI-UNITS LUXEMBOURG has no consensus analysts rating.
What are the forecasts for LYLVD share price target?
According to our own proprietary Forecast Model, LYLVD MULTI-UNITS LUXEMBOURG will be worth about 300.5 in July 2026. The stock is currently trading at 262.75. This means that the stock has a potential upside of +14.35%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 300.5 14.3%